Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

263 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
de la Torre A, García-Berrocal MI, Arias F, Mariño A, Valcárcel F, Magallón R, Regueiro CA, Romero J, Zapata I, de la Fuente C, Fernández-Lizarbe E, Vergara G, Belinchón B, Veiras M, Molerón R, Millán I. de la Torre A, et al. Among authors: de la fuente c. Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):102-10. doi: 10.1016/j.ijrobp.2007.05.068. Epub 2007 Sep 14. Int J Radiat Oncol Biol Phys. 2008. PMID: 17869446 Clinical Trial.
Toxicity and compliance with a chemoradiotherapy schedule for advanced nasopharyngeal carcinoma: a single institution experience using the Intergroup 0099 study regimen.
Chajón EA, García-Berrocal MI, De la Fuente C, Regueiro C, Romero J, Valcárcel F, Magallón R, Hernanz R, De la Torre A. Chajón EA, et al. Among authors: de la fuente c, de la torre a. Acta Oncol. 2005;44(1):85-6. doi: 10.1080/02841860510007459. Acta Oncol. 2005. PMID: 15848912 No abstract available.
Interest of Supportive and Barrier Protective Skin Care Products in the Daily Prevention and Treatment of Cutaneous Toxicity During Radiotherapy for Breast Cancer.
Berger A, Regueiro C, Hijal T, Pasquier D, De La Fuente C, Le Tinier F, Coche-Dequeant B, Lartigau E, Moyal D, Seité S, Bensadoun RJ. Berger A, et al. Among authors: de la fuente c. Breast Cancer (Auckl). 2018 Jan 23;12:1178223417752772. doi: 10.1177/1178223417752772. eCollection 2018. Breast Cancer (Auckl). 2018. PMID: 29434476 Free PMC article.
Is There a Place for Brachytherapy in Vulvar Cancer? A Narrative Review.
Cordoba S, Cordoba A, Gil B, Benlloch R, Rodriguez S, Najjari-Jamal D, Santana S, Bresson L, de la Fuente C, Romero J. Cordoba S, et al. Among authors: de la fuente c. Cancers (Basel). 2023 Nov 25;15(23):5581. doi: 10.3390/cancers15235581. Cancers (Basel). 2023. PMID: 38067285 Free PMC article. Review.
Reirradiation Practice in Gynecological Cancer: Insights from a National Survey in Spain.
Najjari-Jamal D, Rovirosa A, Gimeno-Morales M, Majercakova K, Sánchez M, Garcia S, Guevara D, Muñoz T, De la Fuente C, Micó S, Stefanovic M, Matute R, Córdoba S. Najjari-Jamal D, et al. Among authors: de la fuente c. Clin Transl Oncol. 2024 Dec 5. doi: 10.1007/s12094-024-03804-x. Online ahead of print. Clin Transl Oncol. 2024. PMID: 39636497
Chondral regeneration in femoroacetabular lesions is favoured using peripheral blood stem cells with hyaluronan-based scaffold and micro-drilling: A prospective cohort study.
Monckeberg JE, Rafols C, Gerhard P, Del Canto L, Rosales J, Verdugo MA, Saez C, De la Fuente C. Monckeberg JE, et al. Among authors: de la fuente c. J Exp Orthop. 2024 Aug 30;11(3):e70009. doi: 10.1002/jeo2.70009. eCollection 2024 Jul. J Exp Orthop. 2024. PMID: 39219706 Free PMC article.
263 results